Since ovarian cancer is a chemosensitive disease in most patients [12] we can speculate that the tissue concentration of chemotherapeutics is increased when levels of ADM are elevated, leading to better control of the disease and a longer disease-free interval. Here, ADM is linked to ovarian cancer.